RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034925.xml
PDF herunterladen
Hamostaseologie 2017; 37(01): 9-11
DOI: 10.1055/s-0037-1619830
DOI: 10.1055/s-0037-1619830
Editorial
Progress in Haemostasis
From individual patients to pathophysiological insightsFortschritte in der HämostaseologieVon individuellen Patienten zu pathophysiologischen EinblickenAutoren
Weitere Informationen
Publikationsverlauf
received:
10. Januar 2017
accepted:
10. Januar 2017
Publikationsdatum:
29. Dezember 2017 (online)
-
References
- 1 Scharf RE, Kemkes-Matthes B. Hämostaseologie – Progress in Haemostasis. GTH is moving to a European society. Hämostaseologie 2016; 36: 5-6.
- 2 Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol 1964; 23: 101-112.
- 3 Mourik M, Eikenboom J. Lifecycle of Weibel-Palade bodies. Hämostaseologie 2017; 37: 15-26.
- 4 Byrnes JR, Wolberg AS. New findings on venous thrombogenesis. Hämostaseologie 2017; 37: 27-37.
- 5 Kühne T. Diagnosis and management of immune thrombocytopenia in childhood. Hämostaseologie 2017; 37: 38-46.
- 6 Haas SA, Dettmer V, Cathomen T. Therapeutic genome editing with engineered nucleases. Hämostaseologie 2017; 37: 47-54.
- 7 Scharf RE. Alloantibodies to therapeutic FVIII and the use of emicizumab in hemophilia A. What and how can we do better? Hämostaseologie 2016; 36: 195-198.
- 8 Berntorp E. Plasma-derived versus recombinant factor concentrates in PUPs: a never ending debate?. Hämostaseologie 2017; 37: 55-59.
- 9 Brehm MA. Von Willebrand factor processing. Hämostaseologie 2017; 37: 61-74.